BDBM646494 US20240024403, Compound Albanin

SMILES [#6]\[#6](-[#6])=[#6]/[#6]-c1c(-[#8])ccc(-[#6](=O)-[#6]-2-[#6](-[#6]-[#6](-[#6])=[#6]-[#6]-2-c2c(-[#8])cc(-[#8])c3c2oc(c(-[#6]\[#6]=[#6](\[#6])-[#6])c3=O)-c2ccc(-[#8])cc2-[#8])-c2ccc(-[#8])cc2-[#8])c1-[#8]

InChI Key InChIKey=QTRHXVCWQKBUGL-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 646494   

LigandPNGBDBM646494(US20240024403, Compound Albanin)
Affinity DataIC50: 100nMAssay Description:The CB1 binding assay, described in Example 2, was used to test the Kuwanon G and Albanin G compounds isolated and identified in Example 5. The Kuwan...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2024
Entry Details
Go to US Patent

TargetCannabinoid receptor 2(Human)
Unigen

US Patent
LigandPNGBDBM646494(US20240024403, Compound Albanin)
Affinity DataIC50: 6.60E+3nMAssay Description:The CB1 binding assay, described in Example 2, was used to test the Kuwanon G and Albanin G compounds isolated and identified in Example 5. The Kuwan...More data for this Ligand-Target Pair
In Depth
Date in BDB:
3/19/2024
Entry Details
Go to US Patent